Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROBE: Umbrella Trial of ADCs in Advanced Pancreatic or Breast Cancer
NCT07825753Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab emtansine, trastuzumab deruxtecan, datopotamab deruxtecan, sacituzumab govitecan, enfortumab vedotin, sponsored by Fudan University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
trastuzumab emtansinetrastuzumab deruxtecandatopotamab deruxtecansacituzumab govitecanenfortumab vedotin
Beyond the preview
Go deeper on NCT07825753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07825753.